Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis

Kidney International

Volumn 57, Issue 4, 2000, Pages 1493-1501

  Peters, Harm ^a   Border, Wayne A ^a   Noble, Nancy A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin; Extracellular matrix; Kidney; Low protein diet; Progressive renal disease; TGF

Indexed keywords

ANGIOTENSIN; ENALAPRIL; LOSARTAN; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC GLOMERULONEPHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; DRUG EFFICACY; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RESTRICTION; PROTEIN URINE LEVEL; RAT; TISSUE CULTURE;

EID: 0034072219     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00994.x     Document Type: Conference Paper

References (40)

1. 1. BORDER WA, NOBLE NA: Transforming growth factor-β in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
2. 2. NOBLE NA, BORDER WA: Angiotensin II in renal fibrosis: Should TGF-β rather than blood pressure be the therapeutic target? Semin Nephrol 17:455-466, 1997
3. 3. BORDER WA, OKUDA S, LANGUINO LR, SPORN MB, RUOSLAHTI E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta-1. Nature 346:371-374, 1990
4. 4. BORDER WA, NOBLE NA, YAMAMOTO T, HARPER JR, YAMAGUCHI Y, PIFRSCHBACHER MD, RUOSLAHTI E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360:361-364, 1992
5. 5. ROSENBERG ME, SMITH LJ, CORREA ROTTER R, HOSTETTER TH: The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 45:403-410, 1994
6. 6. BORDER WA, NOBLE NA: Interactions of TGF-β and angiotensin II in renal fibrosis. Hypertension 31:181-188, 1998
7. 7. WOLF G: Molecular mechanisms of angiotensin II in the kidney: Emerging role in the progression of renal disease: Beyond haemodynamics. Nephrol Dial Transplant 13:1131-1142, 1998
8. 8. KAGAMI S, BORDER WA, MILLER DE, NOBLE NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
9. 9. KAGAMI S, KUHARA T, OKADA K, KURODA Y, BORDER WA, NOBLE NA: Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells. Kidney Int 51:664-671, 1997
10. 10. WOLF G, ZIYADEH FN: Renal tubular hypertrophy induced by angiotensin II. Semin Nephrol 17:448-454, 1997
11. 11. WOLF G, ZIYADEH FN, THAISS F, TAMASZEWSKI J, CARON RJ, WENZEL U, ZAHNER G: Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. J Clin Invest 100:1047-1058, 1997
12. 12. SHARMA K, ZIYADEH FN, ALZAHABI B, MCGOWAN TA, KAPOOR S, KURNIK BRC, KURNIK PB, WEISBERG LS: Increased renal production of transforming growth factor-β1 in patients with type II diabetes. Diabetes 46:854-859, 1997
13. 13. PETERS H, BORDER WA, NOBLE NA: Targeting TGF-β overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade. Kidney Int 54:1570-1580, 1998
14. 14. FERN RJ, YESKO CM, THORNHILL BA, KIM H-S, SMITHIES O, CHEVALIER RL: reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. J Clin Invest 103:39-46, 1999
15. 15. FARR LE, SMADEL JE: The effect of dietary protein on the course of nephrotoxic nephritis in rats. J Exp Med 70:615-627, 1939
16. 16. ROSENBERG ME, CHMIELEWSKI D, HOSTETTER TH: Effect of dietary protein and rat renin and angiotensin gene expression. J Clin Invest 85:1144-1149, 1992
17. 17. HOSTETTER TH, MEYER TW, RENNKE HG, BRENNER BM, NODDIN JA, SANDSTROM DJ: Chronic effects of dietary protein in the rat with intact and reduced renal mass. Kidney Int 30:509-517, 1986
18. 18. HEIDLAND A, SEBEKOVA K, LING H: Effect of low-protein diets on renal disease: Are non-haemodynamic factors involved? Nephrol Dial Transplant 10:1512-1514, 1995
19. 19. OKUDA S, NAKAMURA T, YAMAMOTO T, RUOSLAHTI E, BORDER WA: Dietary protein restriction rapidly reduces transforming growth factor β1 expression in experimental glomerulonephritis. Proc Natl Acad Sci USA 88:9765-9769, 1991
20. 20. EDDY AA: Protein restriction reduces transforming growth factor-beta and interstitial fibrosis in nephrotic syndrome. Am J Physiol 266:F884-F893, 1994
21. 21. NAKAYAMA M, OKUDA S, TAMAKI K, FUJISHIMA M: Short-or long-term effects of a low protein diet on fibronectin and transforming growth factor-beta synthesis in ariamycin-induced nephropathy. J Lab Clin Med 127:29-39, 1996
22. 22. RENNARD SI, BERG R. MARTIN GR, FOIDART JM, ROBEY PG: Enzyme-linked immunoassay (ELISA) for connective tissue components. Anal Biochem 104:205-214, 1980
23. 23. FORT P, MARTY L, PIECHACZYK M, SABROUTY SE, DANI C, JEANTEUR PH, BLANCHARD JM: Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 13:1431-1442, 1985
24. 24. DERYNCK R, JARRETT A, CHEN EY, GOEDDEL DV: The murine transforming growth factor-β precursor. J Biol Chem 261:4377-4379, 1986
25. 25. SCHWARZBAUER JE, TAMKUN JW, LEMISCHKA IR, HYNES RO: Three different fibronectin mRNAs arise by alternative splicing within the coding region. Cell 35:421-431, 1983
26. 26. ZEHEB R, GELEHRTER TD: Cloning and sequencing of cDNA for the rat plasminogen activator inhihitor-1. Gene 73:459-468, 1988
27. 27. PETERS H, BORDER WA, NOBLE NA: Tandem antifibrotic actions of L-arginine supplementation and low protein diet during the repair phase of experimental glomerulonephritis. Kidney Int 55:2264-2273, 1999
28. 28. CARTWRIGHT ME, JAENKE RS: Effects of dietary protein and captopril on glomerular permselectivity in rats with unilateral nephrectomy. Lab Invest 59:492-499, 1988
29. 29. ICHIKAWA I: Will angiotensin II receptor antagonists be renoproteclive in humans? Kidney Int 50:684-692, 1996
30. 30. CAMPBELL DJ, KLADIS A, VALENTIJN AJ: Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme. J Cardiovasc Pharmacol 26:233-240, 1995
31. 31. SIRAGY HM, CAREY RM: The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3′,5′-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. J Clin Invest 97:1978-1982, 1996
32. 32. NARITA I, BORDER WA, KETTELER M, RUOSLAHTI E, NOBLE NA: L-arginine may mediate the therapeutic effects of low protein diets. Proc Natl Acad Sci USA 92:4552-4556, 1995
33. 33. PETERS H, NOBLE NA: Dietary L-arginine in renal disease. Semin Nephrol 16:567-575, 1996
34. 34. ROSMAN JB, TER-WEE PM, MEIJER S, PIERS-BECHT TP, SLUTTER WJ, DONKER AJ: Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet 2:1291-1296, 1984
35. 35. KLAHR S, LEVEY AS, BECK GJ, CAGGIULA AW, HUNSICKER L, KUSEK JW, STRIKER G: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease: Modification of Diet in Renal Disease Study Group. N Engl J Med 330:877-884, 1994
36. 36. LEVEY AS, ADLER S, CAGGIULA AW, ENGLAND BK, GREENE T, HUNSICKER LG, KUSEK JW, ROGERS NL, TESCHAN PE: Effects of dietary protein restriction on the progression of advanced renal disease in the modification of diet in renal disease study. Am J Kidney Dis 27:652-663, 1996
37. 37. IHLE BU, BECKER GJ, WHITWORTH JA, CHARLWOOD RA, KINCAID SMITH PS: The effect of protein restriction on the progression of renal insufficiency. N Engl J Med 321:1773-1777, 1989
38. 38. IWANO M, KUBO A, NISHINO T, SATO H, NISHIOKA H, AKAI Y, KLIRIOKA H, FUJII Y, KANAUCHI M, SHIIKI H, DOHI K: Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitus. Kidney Int 49:1120-1126, 1996
39. 39. YAMAMOTO T, NOBLE NA, COHEN AH, NAST CC, HISHIDA A, GOLD LI, BORDER WA: Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int 49:461-469, 1996
40. 40. YAMAMOTO T, NOBLE NA, MILLER DE, GOLD LI, HISHIDA A, NAGASE M, COHEN AH, BORDER WA: Increased levels of TGF-β in HIV-associated nephropathy. Kidney Int 55:579-592, 1999